Table 4 Relationship between expression of cytoplasmic and nuclear (a) p-p38, cell cycle markers, p-ERK1/2, p-Akt and p-JNK in primary melanomas and (b) p-JNK, cell cycle markers, p-ERK1/2, p-p38 and p-Akt in primary melanomas
(a) | ||||||
|---|---|---|---|---|---|---|
Type of lesions | No. of tumors analyzed | Immunohistochemistry | Expression of p-p38 | |||
Marker | Expression level | Low | High | P | ||
Cytoplasmic expression | ||||||
Superficial spreading | 94 | p-ERK cyta | Low | 42 | 1 | <0.0005 |
High | 34 | 17 | ||||
90 | p-Akt cyta | Low | 27 | 2 | 0.047 | |
High | 45 | 16 | ||||
89 | p-JNK cyta | Low | 63 | 10 | 0.003 | |
High | 8 | 8 | ||||
Nodular | Cytoplasmic expression | |||||
58 | p-JNK cyta | Low | 86 | 6 | 0.057 | |
High | 41 | 8 | ||||
Nuclear expression | ||||||
54 | Ki-67 | Low | 25 | 0 | 0.012 | |
High | 22 | 7 | ||||
55 | p-TrkA cyta | Low | 26 | 2 | 0.078 | |
High | 20 | 7 | ||||
55 | p-TrkA memb | Low | 32 | 2 | 0.02 | |
High | 14 | 7 | ||||
(b) | ||||||
|---|---|---|---|---|---|---|
Type of lesion | No. of tumors analyzed | Immunohistochemistry | Ekpression of p-JNK | |||
Marker | Expression level | Low | High | P | ||
Cytoplasmic expression | ||||||
Superficial spreading | 86 | Cyclin A | Low | 52 | 6 | 0.017 |
High | 19 | 9 | ||||
86 | Cyclin D3 | Low | 59 | 9 | 0.075 | |
High | 12 | 6 | ||||
86 | Ki-67 | Low | 58 | 9 | 0.088 | |
High | 13 | 6 | ||||
56 | p21WAF/CIP1 | Low | 29 | 4 | 0.021 | |
High | 14 | 9 | ||||
96 | p-ERK cyta | Low | 39 | 2 | 0.005 | |
High | 38 | 14 | ||||
Nodular | Cytoplasmic expression | |||||
55 | Cyclin D3 | Low | 29 | 1 | 0.082 | |
High | 20 | 5 | ||||
Nuclear expression | ||||||
57 | p-Akt cyta | Low | 13 | 2 | 0.059 | |
High | 24 | 18 | ||||